Option chain shows key data for Valneva's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Valneva.

Valneva (NASDAQ:VALN) Stock, Option Chain

Valneva

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Brazil,On,The,World,Globe,-,A,Close,Up,Shot

Biotech

News

Health Care

Global

Movers

Trading Ideas

General

VALN

Valneva&#39;s chikungunya vaccine Ixchiq receives Brazil approval, enabling expanded trials and access across Latin America and endemic regions.

Brazil Approves Valneva&#39;s Mosquito-Borne Chikungunya Vaccine

Gamestop, Lululemon, Uber, Ulta Beauty And Tesla: Why These 5 Stocks Are On Investors' Radars Today

Intraday Update

Markets

NNNN

SBAC

SKBL

Lamb Weston Posts Better-Than-Expected Results, Joins Sanofi And Other Big Stocks Moving Higher On Thursday

bz_pharma_briefs

Valneva Vaccine Shows Sustained Immune Response In Adolescents One Year After Single Shot

Valneva SE

Press Releases

Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

Valneva Receives First Marketing Authorization for IXCHIQ®  in a Chikungunya Endemic Country

Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®

Legal

Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers

Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities

PARIS:VLA

PARIS:VLAP

Abivax

Bicycle Therapeutics plc - American Depositary Shares

Bicycle Therapeutics

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics

Cogent Biosciences

Immatics

Jade Biosciences

Keros Therapeutics

Kura Oncology

MeiraGTx Hldgs

Organogenesis Holdings

Precigen

Pharming Group N.V. - ADS, each representing 10 ordinary shares

Pharming

Prothena Corporation plc - Ordinary Shares

Prothena Corp

Regulus Therapeutics

Regenxbio

Relay Therapeutics

Sage Therapeutics

Sionna Therapeutics

Stoke Therapeutics

Savara

Tourmaline Bio

Tyra Biosciences

Upstream Bio

Verve Therapeutics

HC Wainwright & Co.

Guggenheim

Comments

Valneva

Valneva (VALN) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell